Smoking Cessation, Uganda
Smoking Cessation, Uganda @beautyuganda_com: Quit/stop smoking with the medication Champix®. Smoking cessation clinic, Uganda. Private and confidential services. Definitions, references, and latest news.
Keywords: Smoking Cessation Uganda, Uganda Smoking Cessation, Smoking Cessation.
Quit smoking with the medication Champix®. Revolutionary new way to stop smoking at our smoking cessation clinic. Get away from the harmful effects of smoking, without feeling the effects of withdrawal!
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Smoking Cessation, Uganda
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.
Thu, 28 Aug 2014 00:00:00 +0100 | Neuropharmacology
Authors: Thompson AJ, Verheij MH, Verbeek J, Windhorst AD, de Esch IJ, Lummis SC
CHANTIX (Varenicline Tartrate) Tablet, Film Coated [Carilion Materials Management]
Wed, 20 Aug 2014 05:00:00 +0100 | DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)
Updated Date: Aug 20, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Permeability Analysis of Neuroactive Drugs Through a Dynamic Microfluidic In Vitro Blood-Brain Barrier Model.
Wed, 13 Aug 2014 00:00:00 +0100 | Annals of Biomedical Engineering
Authors: Booth R, Kim H
Culturally Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial
Tue, 05 Aug 2014 00:00:00 +0100 | The Counseling Psychologist
This collaborative, community-engaged project developed and tested a Culturally Tailored Treatment (CTT) for American Indian/Alaska Native (AI/AN) smokers in the Menominee tribal community. One hundred three adult AI/AN smokers were randomized to receive either Standard Treatment (ST; n = 53) or CTT (n = 50) for smoking cessation. Both treatment conditions included 12 weeks of varenicline and four individual counseling sessions but differed in terms of cultural tailoring of the counseling. The primary outcome was 7-day, biochemically confirmed point-prevalence abstinence (PPA) at the 6-month end-of-study visit. Both intention-to-treat (ITT) and responder-only analyses were conducted. There were no statistically significant group differences in 7-day PPA. The overall ITT abstinence rate at ...
Varenicline in the Treatment of Alcohol Use Disorders.
Tue, 05 Aug 2014 00:00:00 +0100 | The Annals of Pharmacotherapy
CONCLUSIONS: Evidence supports the use of varenicline for the reduction of alcohol craving as well as for the reduction of overall alcohol consumption in patients with alcohol use disorders. However, it is not likely to improve abstinence rates. Although most of the data were derived from patients with concurrent nicotine dependence, the effects of varenicline appear to occur independent of baseline smoking status.
An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers.
Fri, 25 Jul 2014 00:00:00 +0100 | The American Journal of Drug and Alcohol Abuse
Conclusions: These preliminary data provide the first demonstration of safety and feasibility of the co-administration of NAC and VAR in cigarette smokers. AEs were consistent with those typically reported for VAR and NAC. These data support future efficacy research on NAC and VAR for smoking cessation.
Cytisine is effective for smoking cessation: should clinicians use it?
Fri, 18 Jul 2014 00:00:00 +0100 | Evidence-Based Medicine
Commentary on: Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax 2013;68:1037–42 Context Tobacco use remains a leading cause of avoidable premature mortality and morbidity worldwide with approximately 800 million male and 200 million female smokers worldwide.1 Much of this ongoing disease burden can be avoided through smoking cessation. However, nicotine in tobacco smoke is highly addicting and most cessation attempts fail. There are diverse approaches to increase the success rate of quit attempts, including approved pharmacological therapies: nicotine-replacement therapy (NRT; available in several forms and over-the-counter), bupropion (an antidepressant) and varenicline (a partial nicotine agonist). Each of these...
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
Fri, 11 Jul 2014 15:43:00 +0100 | MedPage Today Cardiovascular
(MedPage Today) -- This week's topics include a look at neuropathic pain treatment, infusion pumps for hard to control diabetes, screening for carotid artery stenosis, and varenicline and nicotine replacement for smoking cessation. (Source: MedPage Today Cardiovascular)
Study: combination of varenicline and nicotine patch best way to quit smoking
Wed, 09 Jul 2014 18:09:35 +0100 | Health News - UPI.com
Brooks HaysWASHINGTON, July 9 (UPI) -- The best way to quit smoking, researchers say, is a combination of a drug called varenicline and the use of nicotine patches. (Source: Health News - UPI.com)
Combining varenicline with nicotine patch boosts quit rates
Wed, 09 Jul 2014 00:00:00 +0100 | OnMedica Latest News
Quitters more likely not to be smoking at six months with combination than with varenicline aloneRelated items from OnMedicaFewer smokers are using NHS help to quitSmoking cessationEU moves to make smoking less attractive to young smokersRoll-ups worse than factory-made cigarettesE-cigarettes may not help smokers quit (Source: OnMedica Latest News)